Mycobacterium tuberculosisBeijing Genotype and Risk for Treatment Failure and Relapse, Vietnam
Open Access
- 1 December 2003
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (12) , 1633-1635
- https://doi.org/10.3201/eid0912.030169
Abstract
Among 2,901 new smear-positive tuberculosis cases in Ho Chi Minh City, Vietnam, 40 cases of treatment failure and 39 relapsing cases were diagnosed. All initial and follow-up Mycobacterium tuberculosis isolates of these case-patients had (nearly) identical restriction fragment length polymorphism patterns, and the Beijing genotype was a significant risk factor for treatment failure and relapse (odds ratio 2.8, 95% confidence interval 1.5 to 5.2).Keywords
This publication has 24 references indexed in Scilit:
- Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?2003
- Mutations in Putative Mutator Genes ofMycobacterium tuberculosisStrains of the W-Beijing FamilyEmerging Infectious Diseases, 2003
- A marked difference in pathogenesis and immune response induced by differentMycobacterium tuberculosisgenotypesClinical and Experimental Immunology, 2003
- Global dissemination of the Mycobacterium tuberculosis W-Beijing family strainsTrends in Microbiology, 2002
- Spread of Drug-Resistant Pulmonary Tuberculosis in EstoniaJournal of Clinical Microbiology, 2001
- Restriction Fragment Length Polymorphism Typing of MycobacteriaPublished by Springer Nature ,2001
- Mycobacterium tuberculosis Beijing Genotype Emerging in VietnamEmerging Infectious Diseases, 2000
- Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110elements inMycobacterium tuberculosis: non-random integration in thednaA–dnaNregionTubercle and Lung Disease, 1998
- A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomesPublished by American Medical Association (AMA) ,1996
- Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone familyPublished by American Medical Association (AMA) ,1996